Pregnancy and childbirth occur naturally, but still little is known about the signaling mechanisms that induce contractions. Worldwide, premature labor occurs in 12% of all pregnancies and results in 15 million babies being born preterm [1] . Although the cause of preterm labor can vary, understanding alternative signaling pathways that affect muscle contraction could provide additional treatment options in stopping premature labor.
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The uterus is composed of smooth muscle that is innervated with a plexus of nerves that cover the muscle fibers. The plexus contains neurons that have swollen areas called varicosities which contain neurotransmitters. Tyramine and dopamine are both modulators of smooth muscle activity and are found around the smooth muscle of the mouse uterus. Dopamine is a documented neurotransmitter that inhibits smooth muscle contractions while a recent study has found that tyramine, and its specific receptor TAAR1 (trace amine associated receptor 1), are localized within the uterine plexus and can induce uterine contractions [2] . Although dopamine has greater affinity to the vesicular monoamine transporter (VMAT), both modulators can be taken up into synaptic vesicles [3] . It has also been documented that high levels tyramine can displace dopamine, norepinephrine and epinephrine from pre-synaptic vesicles. Identifying and understanding the dynamics of synaptic transmission in the uterus will help uncover the roles that these biogenic amines play in contraction and possibly provide insight to potential treatments that could be used to stop premature labor.
Using both light and electron microscopy, mouse uterine tissue was imaged to determine morphological changes that were induced by treating them with physiological concentrations of either dopamine or tyramine and to correlate localization of these modulators within varicosities at the plexus (not shown). This protocol was approved through the IACUC protocol 15-1388T at Arizona State University (ASU). The tissues were obtained from both a C57BL/6J wild type and a GFP LifeAct transgenic mouse line [4] . Protocols for inducing pseudo-pregnancy, procurement and preparing tissue for immunohistochemistry are detailed in a previous publication [5] . Specific antibody used includes anti-TAAR1 (Santa Cruz Biotechnology). Secondary labeling included Alexa 568 (ThermoFisher). Images were acquired in the core labs housed within the School of Life Sciences at ASU. The instruments used included a Leica SP8 confocal, a JEOl JSM 6300 SEM and a Philips CM12 TEM system. Results of this project found that dopamine and tyramine treated uterine tissue generated changes in the apical plasma membrane including the height and concentration of peripheral microvilli, increased varicosity swelling and synaptic vesicle cycling in addition to increased mitochondria density and localization [6]. (Fig. A) . The number of synaptic vesicles increased in both dopamine (Fig. B ) and tyramine (Fig. C ) treated tissues as well as an increase in mitochondrial recruitment.
